• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Future Prospects for PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Patients With Sarcomas.

作者信息

Macciò Antonio, Madeddu Clelia

机构信息

Department of Gynecologic Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy.

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

出版信息

JAMA Oncol. 2018 Aug 1;4(8):1134. doi: 10.1001/jamaoncol.2018.0875.

DOI:10.1001/jamaoncol.2018.0875
PMID:29902292
Abstract
摘要

相似文献

1
Future Prospects for PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Patients With Sarcomas.肉瘤患者中PD-1靶向治疗、巨噬细胞浸润及吲哚胺2,3-双加氧酶（IDO）途径激活的未来前景
JAMA Oncol. 2018 Aug 1;4(8):1134. doi: 10.1001/jamaoncol.2018.0875.
2
Future Prospects for PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Patients With Sarcomas-Reply.
JAMA Oncol. 2018 Aug 1;4(8):1134-1135. doi: 10.1001/jamaoncol.2018.0895.
3
Evaluation of PD1 and PD-L1 expression in high-grade sarcomas of the limbs in the adults: possible implications of immunotherapy.评估成人肢体高级别肉瘤中 PD1 和 PD-L1 的表达：免疫治疗的可能影响。
J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4 Suppl. 3):289-294. Congress of the Italian Orthopaedic Research Society.
4
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.癌症治疗中巨噬细胞重编程的缺陷：PD-L1/PD-1 的负面影响。
Front Immunol. 2021 Jun 23;12:690869. doi: 10.3389/fimmu.2021.690869. eCollection 2021.
5
Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.程序性细胞死亡配体 1（PD-L1）信号调节巨噬细胞增殖和激活。
Cancer Immunol Res. 2018 Oct;6(10):1260-1273. doi: 10.1158/2326-6066.CIR-17-0537. Epub 2018 Jul 16.
6
Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury.程序性死亡受体 1/B7 同源物 1 阴性共刺激可保护小鼠肝脏免受缺血再灌注损伤。
Hepatology. 2010 Oct;52(4):1380-9. doi: 10.1002/hep.23843.
7
PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials.PD1/PD-L1 靶向治疗晚期软组织肉瘤的疗效：两项 II 期临床试验的汇总分析。
J Hematol Oncol. 2020 May 19;13(1):55. doi: 10.1186/s13045-020-00891-5.
8
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.T细胞浸润和克隆性与软组织肉瘤患者程序性细胞死亡蛋白1和程序性死亡配体1的表达相关。
Cancer. 2017 Sep 1;123(17):3291-3304. doi: 10.1002/cncr.30726. Epub 2017 May 2.
9
Prognostic impact of the tumor immune microenvironment in synovial sarcoma.肿瘤免疫微环境对滑膜肉瘤的预后影响。
Cancer Sci. 2018 Oct;109(10):3043-3054. doi: 10.1111/cas.13769. Epub 2018 Sep 16.
10
Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.阻断B7-H1可抑制慢性肠道炎症的发展。
J Immunol. 2003 Oct 15;171(8):4156-63. doi: 10.4049/jimmunol.171.8.4156.

引用本文的文献

1
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature.转移性巴氏腺腺癌靶向治疗方法的下一代测序全基因组分析：一例典型病例报告及文献综述
Diagnostics (Basel). 2021 Nov 10;11(11):2085. doi: 10.3390/diagnostics11112085.
2
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?COVID-19 和细胞因子风暴综合征：我们对卵巢癌中白细胞介素 6 的了解能否应用于此？
J Ovarian Res. 2021 Feb 8;14(1):28. doi: 10.1186/s13048-021-00772-6.
3
Blocking inflammation to improve immunotherapy of advanced cancer.
阻断炎症反应以改善晚期癌症的免疫疗法。
Immunology. 2020 Apr;159(4):357-364. doi: 10.1111/imm.13164. Epub 2019 Dec 27.
4
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer.下一代测序推动腹腔镜手术与免疫疗法联合成功治疗复发性IVB期宫颈癌和同步性IV期肺癌。
Oncotarget. 2019 Mar 12;10(21):2012-2021. doi: 10.18632/oncotarget.26769.